PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 90 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38 | -81.9% | 14,262 | -71.3% | 0.00% | -85.7% |
| Q4 2022 | $210 | -99.9% | 49,760 | +144.1% | 0.03% | +55.6% |
| Q2 2021 | $187,000 | +12.7% | 20,384 | +25.7% | 0.02% | 0.0% |
| Q4 2020 | $166,000 | +44.3% | 16,213 | +52.4% | 0.02% | +100.0% |
| Q3 2019 | $115,000 | -66.9% | 10,637 | -37.7% | 0.01% | -52.6% |
| Q4 2018 | $347,000 | -47.5% | 17,065 | +209.2% | 0.02% | -42.4% |
| Q3 2017 | $661,000 | – | 5,519 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |